Literature DB >> 16556184

Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.

F Mearin1, X Badía, A Balboa, J Benavent, A M Caballero, E Domínguez-Muñoz, V Garrigues, J M Piqué, M Roset, M Cucala, M Figueras.   

Abstract

BACKGROUND: The natural history of the irritable bowel syndrome is poorly understood. AIM: To assess the clinical course of the irritable bowel syndrome and the factors that might predict it.
METHODS: An observational prospective study, involving 400 irritable bowel syndrome patients meeting Rome II criteria. Symptoms were recorded in a diary over four non-consecutive months (1, 4, 7 and 10). Demographic data, associated disorders, psychological status and health-related quality of life were obtained.
RESULTS: At 1-year follow-up, half of the patients and half of their physicians considered irritable bowel syndrome to have improved, but improvement was minor. Diary data showed that, according to the type of symptom, improvement was small and quite different: diarrhoea in 19% of patients, abdominal pain frequency in 26%, constipation in 33% and abdominal pain intensity in 60%. Factors related to improvement at one year were: severe symptoms and poor health-related quality of life at first visit, irritable bowel syndrome-constipation, good improvement at 3 months, anxiety/depression, stress, symptoms related to meals and absence of comorbidity. By multivariate logistic regression, predictors were: severe basal symptoms and good improvement at 3 months (OR:CI 95%, 1.32:1.09-1.59 and 4.44:2.81-7.05).
CONCLUSIONS: At 1-year follow-up, half the patients and their physicians considered the irritable bowel syndrome to have had some improvement but, symptom diaries demonstrated that improvement was small and heterogeneous. Severe basal symptoms and improvement at 3 months were related to better prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16556184     DOI: 10.1111/j.1365-2036.2006.02828.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

Review 1.  Irritable bowel syndrome.

Authors:  Antonella Spinelli
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

2.  Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.

Authors:  Mark Fisher; Andrew Walker; Meritxell Falqués; Miguel Moya; Mark Rance; Douglas Taylor; Leandro Lindner
Journal:  Eur J Health Econ       Date:  2016-01-04

Review 3.  Functional gastrointestinal disorders: past and present.

Authors:  Rana Fayez Ammoury; Marian Del Rosario Pfefferkorn; Joseph Marino Croffie
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

4.  Insights into normal and disordered bowel habits from bowel diaries.

Authors:  Adil E Bharucha; Barbara M Seide; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2007-11-16       Impact factor: 10.864

5.  Comprehensive psychological intervention to improve outcome in functional gastrointestinal disorder: a cohort study.

Authors:  Yu Tien Wang; Kah Foo Victor Kwok; Shian Ming Tan; Ming Hwei Yek; Wai Choung Ong; Sylvaine Barbier; Beng Yeong Ng
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

6.  Homeopathy for treatment of irritable bowel syndrome.

Authors:  Emily J Peckham; Katy Cooper; E Rachel Roberts; Anurag Agrawal; Sally Brabyn; Garry Tew
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

7.  Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Gerald J Holtmann; Jane M Andrews
Journal:  Biopsychosoc Med       Date:  2008-06-06

8.  Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care.

Authors:  Åshild Faresjö; Ewa Grodzinsky; Claes Hallert; Toomas Timpka
Journal:  BMC Public Health       Date:  2013-09-11       Impact factor: 3.295

9.  A protocol for a trial of homeopathic treatment for irritable bowel syndrome.

Authors:  Emily J Peckham; Clare Relton; Jackie Raw; Clare Walters; Kate Thomas; Christine Smith
Journal:  BMC Complement Altern Med       Date:  2012-11-06       Impact factor: 3.659

Review 10.  Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review.

Authors:  John K Triantafillidis; George Malgarinos
Journal:  Clin Exp Gastroenterol       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.